Literature DB >> 6187428

The neuroendocrine products of intestinal carcinoids. An immunoperoxidase study of 35 carcinoid tumors stained for serotonin and eight polypeptide hormones.

K Yang, T Ulich, L Cheng, K J Lewin.   

Abstract

The intestinal carcinoid tumors of 26 patients were stained for the presence of serotonin, gastrin, somatostatin, motilin, secretin, glucagon, pancreatic polypeptide, ACTH, and neurotensin. Argentaffin and argyrophil stains were also performed in all cases. Thirty-five separate tumors (counting metastases and multiple primaries) from the 26 patients were studied. Serotonin was present in 30 of the 35 tumors. Nineteen tumors contained serotonin only. Fourteen tumors contained multiple neuroendocrine products. One tumor contained gastrin only. One tumor did not stain immunohistochemically, but was argyrophilic. Metastatic deposits were studied in nine patients. Some metastases produced the identical neuroendocrine products as the primary tumor, whereas others produced either additional or fewer hormones than the primary tumor. Moreover, different metastases from the same primary tumor were observed to produce different hormones. Argyrophilic cells were present in all cases and were much more numerous than cells staining by immunohistochemistry. Argyrophilic cells probably contain monoamines and polypeptide hormones in addition to those studied in this series. The argyrophil stain was the best general stain in this study for the demonstration of neuroendocrine cells. Argentaffin staining was negative in ten cases that were serotonin positive and two argentaffin positive cases were serotonin negative. The carcinoid syndrome, as clinically defined by the presence of flushing and diarrhea, was noted in five patients, all of whom had serotonin-containing small bowel carcinoids. Endocrine-related symptoms were not clinically appreciated in the remaining patients.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6187428     DOI: 10.1002/1097-0142(19830515)51:10<1918::aid-cncr2820511027>3.0.co;2-y

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  12 in total

Review 1.  Revised classification of neuroendocrine tumours of the lung, pancreas and gut.

Authors:  C Capella; P U Heitz; H Höfler; E Solcia; G Klöppel
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

2.  Pre-treatment with somatostatin in the anaesthetic management of a patient with carcinoid syndrome.

Authors:  W C Parris; J A Oates; J Kambam; R Shmerling; J F Sawyers
Journal:  Can J Anaesth       Date:  1988-07       Impact factor: 5.063

3.  Heterogeneity in a colonic carcinoid tumor.

Authors:  P Watson; N M Pettigrew; I Carr
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1986

4.  Argentaffin and argyrophil reactions and serotonin content of endocrine tumours.

Authors:  C A Wells; S M Taylor; A C Cuello
Journal:  J Clin Pathol       Date:  1985-01       Impact factor: 3.411

5.  Presence of sorbin in human digestive tract and endocrine digestive tumours.

Authors:  F Abou El Fadil-Nicol; F Berger; M Descroix-Vagne; D Pansu
Journal:  Gut       Date:  2000-02       Impact factor: 23.059

6.  Disseminated rectal carcinoid tumor with production of immunoreactive motilin.

Authors:  Knut Grönstad; Lars Grimelius; Rolf Ekman; Jan Kewenter; Håkan Ahlman
Journal:  Endocr Pathol       Date:  1992-12       Impact factor: 3.943

Review 7.  Eye of newt and toe of frog: substance P and the charmed pot of neuropeptides.

Authors:  P Skrabanek
Journal:  Ir J Med Sci       Date:  1984-02       Impact factor: 1.568

8.  Growth-hormone-releasing factor immunoreactivity in human endocrine tumors.

Authors:  D G Bostwick; R Quan; A R Hoffman; R J Webber; J K Chang; K G Bensch
Journal:  Am J Pathol       Date:  1984-11       Impact factor: 4.307

Review 9.  Endocrine cells producing regulatory peptides.

Authors:  E Solcia; L Usellini; R Buffa; G Rindi; L Villani; C Zampatti; E Silini
Journal:  Experientia       Date:  1987-07-15

10.  Comparison of immunological detection of 5-hydroxytryptamine by monoclonal antibodies with standard silver stains as an aid to diagnosing carcinoid tumours.

Authors:  P A Shaw
Journal:  J Clin Pathol       Date:  1988-03       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.